Drug intelligence / Profile preview

imipenem-cilastatin + meropenem

Development stage
Unknown
Lead developer
Merck
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

This represents a comparison of two distinct carbapenem antibiotics rather than a single combination product. Imipenem-cilastatin (Primaxin) combines imipenem (a carbapenem antibiotic) with cilastatin (a dehydropeptidase inhibitor that prevents the breakdown of imipenem). Meropenem (Merrem) is another carbapenem antibiotic that does not require a dehydropeptidase inhibitor. Both medications are broad-spectrum beta-lactam antibiotics used to treat serious bacterial infections. Clinical trials have directly compared these two treatment options for various infections including complicated skin and skin structure infections, pneumonia, and other severe bacterial infections.

Brand names
Primaxin + Merrem
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on imipenem-cilastatin + meropenem.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on imipenem-cilastatin + meropenem.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call